On June 16, the Green Congress was held with a focus on the environment and updates from the EULAR congress.
Editorial in Dagens Medisin that highlights that user participation can lead to better research.
This year's EULAR congress was held in Europe's largest congress center in Milan. As many as 50 Norwegian contributions were presented, 30 of them from Diakonhjemmet Hospital.
The Nor-vaC study is one of the projects featured in the National Report from the Specialist Health Service 2022 - Research and innovation for the benefit of patients.
Results from the ARCTIC REWIND study indicate that some arthritis patients can manage without medication.
The first annual report of the REMEDY Center has now been published.
The REMEDY research seminar for 2023 was held on March 22-23 at Sanner Hotel with 120 registered participants. On 24 March, the Young researcher program had a separate session with almost 50 participants.
This week, it was formally announced that Daniel H. Solomon, Professor at Harvard Medical School (Boston, USA) will be an official visiting professor at the REMEDY research center.
Diakonhjemmet Hospital was awarded funding from the South-Eastern Norway Regional Health Authority for eight research projects, four of which are part of REMEDY. Three of the studies receiving funding are related to digital home follow-up/eHealth, while the fourth is a clinical study on hip fractures.
The Nor-vaC study concludes that repeated COVID-19 vaccination is safe and that it strengthens the antibody response in patients with inflammatory diseases of the joints and gut.
Researcher Nina Østerås has presented the new research-based advice for osteoarthritis in VG. She emphasizes that even if the joints are affected by osteoarthritis, movement and adapted exercise will lead to better joint health.
As part of the European SQUEEZE collaboration, REMEDY receives 13 million to investigate therapeutic drug monitoring.
On September 20-21, a start-up seminar was organized in REMEDY. The seminar lays the foundation for further collaboration to research rheumatic and musculoskeletal diseases in the future.
On International Clinical Trials Day (May 20), the Research Center for Rheumatology and Musculoskeletal Diseases (REMEDY) was officially declared open at Diakonhjemmet Hospital. The REMEDY center is supported by research funding from the Research Council of Norway and the Olav Thon Foundation.
In competition with many strong research environments in Norway, the Research Council has awarded Diakonhjemmet Hospital up to NOK 128 million to establish a research center for treatment in rheumatology and musculoskeletal diseases. This research initiative will provide better treatment for a large group of patients.